Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT02758132
Title Denosumab Plus Enzalutamide, Abiraterone and Prednisone Compared to Denosumab Plus Enzalutamide Alone for Men With Castrate Resistant Prostate Cancer (CRPC) With Bone Metastases
Recruitment Terminated
Gender male
Phase Phase I
Variant Requirements No
Sponsors University of Hawaii
Indications
Therapies
Age Groups: adult
Covered Countries USA

Facility Status City State Zip Country Details
University of Hawaii Cancer Center Honolulu Hawaii 96813 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field